Sellas Life Sciences Group Inc (SLS)
Change in Working Capital
$848.00K
Quarterly · Period ending: · USD
SLS Change in Working Capital
Latest reported$848.00Kperiod ending
Latest reported$848.00Kperiod ending
SLS Quarterly Change in Working Capital ($163.00K → $848.00K)
Quarterly change in working capital
High-resolution chart · PNG
SLS change in working capital history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Change in Working Capital (USD) |
|---|---|
| 848,000 | |
| -1,390,000 | |
| 2,136,000 | |
| -927,000 | |
| -1,379,000 | |
| -3,909,000 | |
| -937,000 | |
| -1,216,000 | |
| -1,625,000 | |
| -1,809,000 | |
| 2,686,000 | |
| 1,710,000 | |
| 604,000 | |
| -1,655,000 | |
| 3,567,000 | |
| 627,000 | |
| 2,284,000 | |
| -837,000 | |
| 484,000 | |
| 822,000 | |
| 135,000 | |
| -9,056,000 | |
| 7,168,000 | |
| 643,000 | |
| 715,000 | |
| -2,936,000 | |
| 310,000 | |
| 194,000 | |
| -785,000 | |
| -831,000 | |
| 1,403,000 | |
| -10,712,000 | |
| -1,032,000 | |
| 335,000 | |
| 7,343,000 | |
| 338,000 | |
| -968,000 | |
| -648,000 | |
| 1,880,000 | |
| -6,123,000 | |
| 738,000 | |
| -21,410,000 | |
| 22,103,000 | |
| 429,000 | |
| -1,579,000 | |
| -1,080,000 | |
| -552,000 | |
| 896,000 | |
| 1,384,000 | |
| 2,259,000 | |
| 2,520,000 | |
| -1,420,000 | |
| 497,000 | |
| 912,000 | |
| 58,000 | |
| 997,000 | |
| -909,000 | |
| -40,000 | |
| 1,318,000 | |
| 586,000 | |
| -148,000 | |
| 799,000 | |
| 9,000 | |
| -136,000 | |
| -23,000 | |
| 462,000 | |
| -184,000 | |
| 245,000 | |
| 437,000 | |
| -213,000 | |
| 418,000 | |
| -268,000 | |
| -266,000 | |
| 111,000 | |
| 199,000 | |
| -319,000 | |
| 452,000 | |
| 342,000 | |
| 163,000 |